After another busy day of market bashing, economic woes and company announcements, musical companies seem to be proving their worth. Read on for the second part of today's Coronavirus update.
Winners: success in unlikely places
Medical authorities in China have said a drug developed by a subsidiary of Fujifilm Holdings (Japan:4901) used in Japan to treat new strains of influenza appeared to be effective in coronavirus patients.An official at China’s science and technology ministry, said favipiravir, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients. Despite no official comment from the company, shares in Fujifilm Holdings soared on the news.
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.
